Logo image of ETHZ

ETHZILLA CORP (ETHZ) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ETHZ - US68236V4014 - Common Stock

5.59 USD
+0.17 (+3.14%)
Last: 1/16/2026, 8:10:20 PM
5.6 USD
+0.01 (+0.18%)
After Hours: 1/16/2026, 8:10:20 PM
Fundamental Rating

1

Overall ETHZ gets a fundamental rating of 1 out of 10. We evaluated ETHZ against 525 industry peers in the Biotechnology industry. ETHZ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ETHZ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ETHZ has reported negative net income.
  • In the past year ETHZ has reported a negative cash flow from operations.
  • In the past 5 years ETHZ always reported negative net income.
  • In the past 5 years ETHZ always reported negative operating cash flow.
ETHZ Yearly Net Income VS EBIT VS OCF VS FCFETHZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • ETHZ's Return On Assets of -23.10% is fine compared to the rest of the industry. ETHZ outperforms 73.71% of its industry peers.
  • ETHZ has a better Return On Equity (-52.37%) than 65.90% of its industry peers.
Industry RankSector Rank
ROA -23.1%
ROE -52.37%
ROIC N/A
ROA(3y)-229.08%
ROA(5y)-148.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ETHZ Yearly ROA, ROE, ROICETHZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K -5K 10K 15K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ETHZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ETHZ Yearly Profit, Operating, Gross MarginsETHZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

  • The number of shares outstanding for ETHZ has been increased compared to 1 year ago.
  • ETHZ has more shares outstanding than it did 5 years ago.
  • ETHZ has a better debt/assets ratio than last year.
ETHZ Yearly Shares OutstandingETHZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K
ETHZ Yearly Total Debt VS Total AssetsETHZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • ETHZ has an Altman-Z score of -0.49. This is a bad value and indicates that ETHZ is not financially healthy and even has some risk of bankruptcy.
  • ETHZ's Altman-Z score of -0.49 is in line compared to the rest of the industry. ETHZ outperforms 58.67% of its industry peers.
  • ETHZ has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of ETHZ (1.11) is worse than 75.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Altman-Z -0.49
ROIC/WACCN/A
WACCN/A
ETHZ Yearly LT Debt VS Equity VS FCFETHZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 10.07 indicates that ETHZ has no problem at all paying its short term obligations.
  • ETHZ has a Current ratio of 10.07. This is amongst the best in the industry. ETHZ outperforms 80.95% of its industry peers.
  • A Quick Ratio of 10.07 indicates that ETHZ has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 10.07, ETHZ belongs to the best of the industry, outperforming 81.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.07
Quick Ratio 10.07
ETHZ Yearly Current Assets VS Current LiabilitesETHZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

  • The earnings per share for ETHZ have decreased strongly by -204.39% in the last year.
EPS 1Y (TTM)-204.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year54.15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ETHZ Yearly Revenue VS EstimatesETHZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2M 4M 6M 8M 10M
ETHZ Yearly EPS VS EstimatesETHZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -1K -2K -3K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • ETHZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ETHZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ETHZ Price Earnings VS Forward Price EarningsETHZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ETHZ Per share dataETHZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for ETHZ!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ETHZILLA CORP

NASDAQ:ETHZ (1/16/2026, 8:10:20 PM)

After market: 5.6 +0.01 (+0.18%)

5.59

+0.17 (+3.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14
Earnings (Next)03-30
Inst Owners23.24%
Inst Owner ChangeN/A
Ins Owners20.7%
Ins Owner Change79.09%
Market Cap107.89M
Revenue(TTM)4.11M
Net Income(TTM)-233.12M
Analysts82.86
Price TargetN/A
Short Float %20.76%
Short Ratio1.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 26.25
P/FCF N/A
P/OCF N/A
P/B 0.24
P/tB 0.24
EV/EBITDA N/A
EPS(TTM)-136.67
EYN/A
EPS(NY)-3.06
Fwd EYN/A
FCF(TTM)-1
FCFYN/A
OCF(TTM)-1
OCFYN/A
SpS0.21
BVpS23.06
TBVpS23.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -23.1%
ROE -52.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-229.08%
ROA(5y)-148.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.07
Quick Ratio 10.07
Altman-Z -0.49
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-204.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.86%
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year54.15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3310.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-65.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65.7%
OCF growth 3YN/A
OCF growth 5YN/A

ETHZILLA CORP / ETHZ FAQ

Can you provide the ChartMill fundamental rating for ETHZILLA CORP?

ChartMill assigns a fundamental rating of 1 / 10 to ETHZ.


Can you provide the valuation status for ETHZILLA CORP?

ChartMill assigns a valuation rating of 0 / 10 to ETHZILLA CORP (ETHZ). This can be considered as Overvalued.


What is the profitability of ETHZ stock?

ETHZILLA CORP (ETHZ) has a profitability rating of 1 / 10.


How financially healthy is ETHZILLA CORP?

The financial health rating of ETHZILLA CORP (ETHZ) is 4 / 10.